Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11583529 Treatment of inflammatory disorders

Patent 11583529 was granted and assigned to Aldeyra Therapeutics on February, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128013 Toxic aldehyde related diseases and treatment
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064516 Pharmaceutical formulations and uses thereof
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006298 Polymorphic compounds and uses thereof
0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Current Assignee
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115835290
Date of Patent
February 21, 2023
0
Patent Application Number
173287720
Date Filed
May 24, 2021
0
Patent Citations
‌
US Patent 11129823 Combination treatment of ocular inflammatory disorders and diseases
0
‌
US Patent 11197821 Formulations for treatment of dry eye disease
0
‌
US Patent 10058095 Deuterium-enriched aldehydes
0
‌
US Patent 10111862 Traps in the treatment of macular degeneration
0
‌
US Patent 10202348 Compositions and methods of treating retinal disease
0
‌
US Patent 10213395 Toxic aldehyde related diseases and treatment
0
‌
US Patent 10414732 Polymorphic compounds and uses thereof
0
‌
US Patent 10426790 Treatment of allergic eye conditions with cyclodextrins
0
‌
US Patent 10543181 Toxic aldehyde related diseases and treatment
0
‌
US Patent 10550085 Deuterated compounds and uses thereof
0
‌
US Patent 10588874 Toxic aldehyde related diseases and treatment
0
‌
US Patent 11040039 Treatment of inflammatory disorders
0
‌
US Patent 11046650 Deuterated compounds and uses thereof
0
‌
US Patent 11312692 Polymorphic compounds and uses thereof
0
Patent Primary Examiner
‌
Deepak R Rao
0
CPC Code
‌
C07D 215/38
0
‌
A61K 31/47
0
Edits on 22 Feb, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Feb, 2023
Edits made to:
Infobox (+25 properties)
Article (+117 characters)
‌

 US Patent 11583529 Treatment of inflammatory disorders

Article

The present disclosure provides compounds and methods of use thereof for treating inflammatory diseases or disorders.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Current Assignee
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115835290
Date of Patent
February 21, 2023
0
Patent Application Number
173287720
Date Filed
May 24, 2021
0
Patent Citations
‌
US Patent 11129823 Combination treatment of ocular inflammatory disorders and diseases
0
‌
US Patent 11197821 Formulations for treatment of dry eye disease
0
‌
US Patent 10058095 Deuterium-enriched aldehydes
0
‌
US Patent 10111862 Traps in the treatment of macular degeneration
0
‌
US Patent 10202348 Compositions and methods of treating retinal disease
0
‌
US Patent 10213395 Toxic aldehyde related diseases and treatment
0
‌
US Patent 10414732 Polymorphic compounds and uses thereof
0
‌
US Patent 10426790 Treatment of allergic eye conditions with cyclodextrins
0
‌
US Patent 10543181 Toxic aldehyde related diseases and treatment
0
‌
US Patent 10550085 Deuterated compounds and uses thereof
0
‌
US Patent 10588874 Toxic aldehyde related diseases and treatment
0
‌
US Patent 11040039 Treatment of inflammatory disorders
0
‌
US Patent 11046650 Deuterated compounds and uses thereof
0
‌
US Patent 11312692 Polymorphic compounds and uses thereof
0
Patent Primary Examiner
‌
Deepak R Rao
0
CPC Code
‌
C07D 215/38
0
‌
A61K 31/47
0

Find more entities like US Patent 11583529 Treatment of inflammatory disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo